UAE Pharmaceutical Gelatin Market
UAE Pharmaceutical Gelatin Market Size Set to Touch Whopping USD 22.47 Million by 2029
Published | 28 August 2023
UAE Pharmaceutical Gelatin market is gaining traction because of the advantages & properties of gelatin and launch of advanced pharma gelatin.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the UAE Pharmaceutical Gelatin market size at USD 14.81 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the UAE Pharmaceutical Gelatin market size to grow at a CAGR of 7.20% reaching a value of USD 22.47 million by 2029. The expansion of the pharmaceutical industry and considerable research and development in the industry are key driving factors for the UAE Pharmaceutical Gelatin market. Additionally, it is anticipated that the UAE pharmaceutical gelatin market would see considerable development potential due to the growing elderly population and growing awareness of its health advantages.
UAE Pharmaceutical Gelatin Market – Overview
Gelatin is a translucent, colorless protein that is naturally soluble in water. It is a protein made from uncooked animal products. Collagen, the most prevalent protein in the animal kingdom with large amounts seen in connective tissues, is partially hydrolyzed to produce it. Gelatin is utilized as a basic material in emergency medicine to create blood substitutes like plasma expanders. These boost the fluid in the bloodstream, avoiding hypovolemic shock. Gelatin is a protein-rich food that contains amino acids that may improve cognitive function, lessen the effects of aging on the skin, and lessen joint and bone discomfort.
UAE Pharmaceutical Gelatin Market
UAE Pharmaceutical Gelatin Market – By Application
Based on application, the UAE Pharmaceutical Gelatin market is segmented into hard capsules, soft-gel capsules, tablets, absorbable hemostats, and others. Hard capsules dominate the UAE pharmaceutical gelatin market. A hard gelatin capsule is a type of capsule that is usually used to contain medicine in the form of dry powder or very small pellets. The growth of this segment is mainly attributed to the rising consumption of oral medications including tablets and hard gelatin capsules. However, soft-gel capsules are projected to register the highest growth rate during the forecast period.
Impact of COVID-19 on the UAE Pharmaceutical Gelatin Market
The COVID-19 pandemic initially hindered the UAE pharmaceutical gelatin market due to the decline in demand and consumption of animal products. The supply chain restrictions on the pharmaceutical trade also negatively impacted the market growth. However, gelatin emerged as a crucial element in the production of COVID-19 vaccines. In order to stabilize the drug's components and guarantee their effectiveness throughout the distribution process, gelatin derived from pig and cow products is frequently utilized in vaccinations. Although concerns rose regarding the use of pork gelatin in vaccines among the Muslim community of the country, the top Islamic authority in the United Arab Emirates stated on December 23, 2020, that COVID-19 vaccinations are acceptable for Muslims, even if they include pig gelatin.
Major players operating in the UAE Pharmaceutical Gelatin market include Gelita AG, Trobas Pharmaceutical Gelatine B.V, Rousselot, Weishardt, Sterling Gelatin, Catalent, Inc, Nitta Pharmaceutical Gelatin India Limited, Aspire Pharmaceuticals, Junca Gelatines, and Gelco International.
To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the UAE Pharmaceutical Gelatin Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the UAE Pharmaceutical Gelatin Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
BlueWeave Consulting & Research Pvt. Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
- UAE Pharmaceutical Gelatin Market, By Source (Bovine Skin, Bovine Bone, Marine, Poultry); By Function (Stabilizing Agent, Thickening Agent, Gelling Agent, Others); By Type (Type A, Type B); By Application (Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats, Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
Publish Date: August 2023
Advantages & properties of gelatin and the launch of advanced pharma gelatin are expected to boost the growth of UAE Pharmaceutical Gelatin market during the forecast period between 2023 and 2029.
Relevant Press Releases
- Global Perinatal Infections Market Set to Grow at Steady CAGR of 7.3% During 2023–2029
- Australia Regenerative Medicine Market Size Set to Touch USD 1.4 Billion by 2029
- Global Central Fill Pharmacy Automation Market to Reach USD 887 Million by 2028
- Global Aseptic Pharma Processing Equipment Market Projected to Touch Market Worth USD 12.9 Billion: Growing at a CAGR of 7.2% in the Forecast Period
- Global Herpes Simplex Virus (HSV) Treatment Market Size Set to Touch USD 2.17 Billion by 2029